Pantoprazol Nycomed (Pantoprazole)

Pantoprazol Nycomed is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for:

• Gastro‑oesophageal reflux disease (GERD): relief of heartburn and healing of erosive esophagitis.
• Erosive duodenal ulcer: promotes ulcer healing and reduces recurrence.
• Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with this rare endocrine tumor.

• Pantoprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding covalently to the pump’s cysteine residues, it blocks the final step of acid secretion, leading to sustained elevation of gastric pH and reduced acidity in the stomach.

Pantoprazol Nycomed is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhoea: usually self‑limiting.
• Nausea: occasional and transient.
• Abdominal pain: mild discomfort.
• Flatulence: gas‑related bloating.
• Constipation: infrequent.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): requires immediate medical attention.
• Clostridioides difficile‑associated colitis: may present with watery diarrhoea.
• Acute interstitial nephritis: renal function monitoring recommended.
• Low magnesium levels (hypomagnesemia): can cause muscle cramps or cardiac arrhythmia.
• Fracture risk with long‑term use: consider bone health assessment.

Before prescribing Pantoprazol Nycomed, consider the following safety measures:

• Assess renal function: dose adjustment may be required in severe renal impairment.
• Evaluate hepatic function: use with caution in patients with moderate liver disease.
• Review concomitant medications: potential for altered absorption of drugs that require acidic pH.
• Monitor long‑term users: assess need for calcium, vitamin D and bone density evaluation.
• Store below 25°C: keep in the original packaging, protect from moisture and light.

Pantoprazol Nycomed may interact with several medicines; clinical relevance varies.

Major Interactions (Avoid)

• Ketoconazole oral suspension: reduced absorption leading to loss of antifungal efficacy.
• Atazanavir (HIV protease inhibitor): markedly decreased plasma concentrations.

Moderate Interactions (Monitor Closely)

• Warfarin: possible increase in INR‑related bleeding risk.
• Digoxin: modest rise in serum levels.
• Methotrexate (high‑dose): reduced renal clearance may increase toxicity.
• Clopidogrel: potential attenuation of antiplatelet effect.